# April W. Armstrong

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/april-w-armstrong/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,445 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 72 |
| i10-index | 287 |
| Last Known Institution | University of Southern California |
| OpenAlex ID | https://openalex.org/A5033903141 |
| ORCID iD | https://orcid.org/0000-0003-0064-8707 |
| Works | 853 |

## Researcher papers

- [Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics](https://scholariq.org/papers/joint-aad-npf-guidelines-of-care-for-the-management-and-treatment-of-psoriasis/)
- [Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis](https://scholariq.org/papers/phase-3-studies-comparing-brodalumab-with-ustekinumab-in-psoriasis/)
- [Guidelines of care for the management of cutaneous squamous cell carcinoma](https://scholariq.org/papers/guidelines-of-care-for-the-management-of-cutaneous-squamous-cell-carcinoma/)
- [Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities](https://scholariq.org/papers/joint-aad-npf-guidelines-of-care-for-the-management-and-treatment-of-psoriasis-2/)
- [Guidelines of care for the management of basal cell carcinoma](https://scholariq.org/papers/guidelines-of-care-for-the-management-of-basal-cell-carcinoma/)
- [Corticosteroids and wound healing: clinical considerations in the perioperative period](https://scholariq.org/papers/corticosteroids-and-wound-healing-clinical-considerations-in-the-perioperative/)
- [Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial](https://scholariq.org/papers/deucravacitinib-versus-placebo-and-apremilast-in-moderate-to-severe-plaque/)
- [Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies](https://scholariq.org/papers/joint-american-academy-of-dermatology-national-psoriasis-foundation-guidelines/)
- [Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures](https://scholariq.org/papers/joint-aad-npf-guidelines-of-care-for-the-management-and-treatment-of-psoriasis-3/)
- [Comparison of Biologics and Oral Treatments for Plaque Psoriasis](https://scholariq.org/papers/comparison-of-biologics-and-oral-treatments-for-plaque-psoriasis/)
- [Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis](https://scholariq.org/papers/efficacy-and-safety-of-lebrikizumab-in-combination-with-topical-corticosteroids/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)

## Researcher university

- [University of Southern California](https://scholariq.org/institutions/university-of-southern-california/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.